Zhuyi Q. Li
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy.
Journal: Med (New York, N.Y.)
Published: September 15, 2025
Efficacy and safety of efgartigimod versus intravenous immunoglobulin in early intervention of acetylcholine receptor antibody-positive impending myasthenic crisis: A retrospective cohort study.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: May 14, 2025
Efficacy and Safety of Efgartigimod for Patients With Myasthenia Gravis in a Real-World Cohort of 77 Patients.
Journal: CNS neuroscience & therapeutics
Published: March 05, 2025
High indirect bilirubin levels as an independent predictor of postoperative myasthenic crisis: a single-center, retrospective study.
Journal: Frontiers in neurology
Published: November 15, 2023
Efficacy and safety of tocilizumab in patients with refractory generalized myasthenia gravis.
Journal: CNS neuroscience & therapeutics
Published: September 30, 2023
A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis.
Journal: European journal of neurology
Published: September 05, 2023
Emerging trends and research foci of neuromyelitis optica spectrum disorder: a 20-year bibliometric analysis.
Journal: Frontiers in immunology
Published: March 01, 2023
Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis.
Journal: Journal of translational medicine
Published: December 26, 2022
Nomogram for predicting the risk of postoperative myasthenic crisis in patients with thymectomy.
Journal: Annals of clinical and translational neurology
Published: November 27, 2022
Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis.
Journal: Frontiers in immunology
Published: July 19, 2022
Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis.
Journal: Frontiers in immunology
Published: April 01, 2022
Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset.
Journal: Frontiers in neurology
Published: January 18, 2022
Last Updated: 09/26/2026